Evidence map›Paper›PMID 30711007›Full record

ArticleJournal of nanobiotechnology2019

Inhibition of inflammatory response in human keratinocytes by magnetic nanoparticles functionalized with PBP10 peptide derived from the PIP2-binding site of human plasma gelsolin.

Ewelina Piktel, Urszula Wnorowska, Mateusz Cieśluk, Piotr Deptula, Katarzyna Pogoda, Iwona Misztalewska-Turkowicz, Paulina Paprocka, Katarzyna Niemirowicz-Laskowska, Agnieszka Z Wilczewska, Paul A Janmey and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of nanobiotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Anti-Inflammatory Effect of Liverwort (Plants (Basel, Switzerland) · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Susceptibility of microbial cells to the modified PIPJournal of nanobiotechnology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Ewelina PiktelDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Bialystok, Poland.
Urszula WnorowskaDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Bialystok, Poland.
Mateusz CieślukDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Bialystok, Poland.
Piotr DeptulaDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Bialystok, Poland.
Katarzyna PogodaIInstitute of Nuclear Physics Polish Academy of Sciences, PL-31342, Krakow, Poland.
Iwona Misztalewska-TurkowiczInstitute of Chemistry, University of Białystok, Ciołkowskiego 1K, Białystok, Poland.
Paulina PaprockaDepartment of Microbiology and Immunology, The Faculty of Medicine and Health Sciences of the Jan Kochanowski University in Kielce, Kielce, Poland.
Katarzyna Niemirowicz-LaskowskaDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Bialystok, Poland.
Agnieszka Z WilczewskaInstitute of Chemistry, University of Białystok, Ciołkowskiego 1K, Białystok, Poland.
Paul A JanmeyDepartment of Physiology and Institute for Medicine and Engineering, University of Pennsylvania, Philadelphia, PA, USA.
Robert BuckiDepartment of Microbiological and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2c, 15-222, Bialystok, Poland. buckirobert@gmail.com.
Medical University of Białystok · PLUniversity of Białystok · PLInstitute of Nuclear Physics, Polish Academy of Sciences · PLJan Kochanowski University · PLUniversity of Pennsylvania · US

Funding

Spatial control of actin assembly by phosphoinositidesR01GM111942 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI JANMEY, PAUL A · 2015 to 2018
$1.8M
Medical University of Bialystok N/ST/ZB/18/001/1162Medical University of Bialystok N/ST/ZB/18/002/1162Narodowe Centrum Nauki UMO-2015/17/B/NZ6/03473NIGMS NIH HHS R01 GM111942
6 · The paper itself

Abstract

backgroundHuman plasma gelsolin (pGSN) is a multifunctional actin-binding protein involved in a variety of biological processes, including neutralization of pro-inflammatory molecules such as lipopolysaccharide (LPS) and lipoteichoic acid (LTA) and modulation of host inflammatory response. It was found that PBP10, a synthetic rhodamine B-conjugated peptide, based on the phosphoinositide-binding site of pGSN, exerts bactericidal activity against Gram-positive and Gram-negative bacteria, interacts specifically with LPS and LTA, and limits microbial-induced inflammatory effects. The therapeutic efficiency of PBP10 when immobilized on the surface of iron oxide-based magnetic nanoparticles was not evaluated, to date.

resultsUsing the human keratinocyte cell line HaCaT stimulated by bacterially-derived LPS and LTA as an in vitro model of bacterial infection, we examined the anti-inflammatory effects of nanosystems consisting of iron oxide-based magnetic nanoparticles with aminosilane (MNP@NH

conclusionsNeutralization of endotoxemia-mediated cellular effects by gelsolin-derived peptides and PBP10-containing nanosystems might be considered as potent therapeutic agents in the improved therapy of bacterial infections and microbial-induced inflammation.

Indexed as

Anti-Bacterial AgentsBacteriaBinding SitesGelsolinHumansInflammation MediatorsKeratinocytesLipopolysaccharidesMagnetite NanoparticlesPeptide FragmentsPeptidesSkin Diseases, BacterialTeichoic AcidsAnti-Bacterial AgentsGelsolingelsolin (160-169)Inflammation MediatorsLipopolysaccharideslipoteichoic acidMagnetite NanoparticlesPeptide FragmentsPeptidesTeichoic AcidsGelsolinInflammationMagnetic nanoparticlesPBP10Skin diseases

Identifiers

PMID30711007
PMCPMC6359803
OpenAlexW2936378264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.